Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EEV vaccine
- Development stage
- Preclinical
- Lead developer
- Auro Vaccines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
EEV vaccine is a preclinical-stage, viral-vectored prophylactic vaccine being developed by Auro Vaccines (formerly Profectus BioSciences) to protect against encephalitic disease caused by Venezuelan equine encephalitis virus (VEEV), Eastern equine encephalitis virus (EEEV), and Western equine encephalitis virus (WEEV). The vaccine utilizes the proprietary VesiculoVax platform, which employs attenuated, replication-competent recombinant vesiculoviruses (such as vesicular stomatitis virus [rVSV] or Isfahan virus [rISFV]) engineered to express the surface glycoproteins of the target alphaviruses. This approach is designed to stimulate rapid and protective humoral and cellular immune responses against these mosquito-borne biothreat agents.
- Other names
- Eastern Equine Encephalitis vaccineVenezuelan Equine Encephalitis vaccineVesiculoVax EEV vaccineWestern Equine Encephalitis vaccine
02
Targets
EEEV antigen (Eastern equine encephalitis virus antigen)VEEV E polyprotein (Venezuelan equine encephalitis virus envelope polyprotein)WEEV structural protein (Western equine encephalitis virus structural polyprotein)
Beyond the preview
Go deeper on EEV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EEV vaccine.